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Metagenomic Approach for Identification of the Pathogens Associated
with Diarrhea in Stool Specimens
Yanjiao Zhou,a* Kristine M. Wylie,a Rana E. El Feghaly,b Kathie A. Mihindukulasuriya,c Alexis Elward,a David B. Haslam,d
Gregory A. Storch,a George M. Weinstockc*
Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USAa; Department of Pediatrics, University of Mississippi Medical Center, Jackson,
Mississippi, USAb; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri, USAc; Division of Infectious Disease, Cincinnati Children’s
Hospital Medical Center, Cincinnati, Ohio, USAd
The potential to rapidly capture the entire microbial community structure and/or gene content makes metagenomic sequencing
an attractive tool for pathogen identification and the detection of resistance/virulence genes in clinical settings. Here, we as-
sessed the consistency between PCR from a diagnostic laboratory, quantitative PCR (qPCR) from a research laboratory, 16S
rRNA gene sequencing, and metagenomic shotgun sequencing (MSS) for Clostridium difficile identification in diarrhea stool
samples. Twenty-two C. difficile-positive diarrhea samples identified by PCR and qPCR and five C. difficile-negative diarrhea
controls were studied. C. difficile was detected in 90.9% of C. difficile-positive samples using 16S rRNA gene sequencing, and C.
difficile was detected in 86.3% of C. difficile-positive samples using MSS. CFU inferred from qPCR analysis were positively corre-
lated with the relative abundance of C. difficile from 16S rRNA gene sequencing (r20.60) and MSS (r20.55). C. difficile
was codetected with Clostridium perfringens, norovirus, sapovirus, parechovirus, and anellovirus in 3.7% to 27.3% of the sam-
ples. A high load of Candida spp. was found in a symptomatic control sample in which no causative agents for diarrhea were
identified in routine clinical testing. Beta-lactamase and tetracycline resistance genes were the most prevalent (25.9%) antibiotic
resistance genes in these samples. In summary, the proof-of-concept study demonstrated that next-generation sequencing (NGS)
in pathogen detection is moderately correlated with laboratory testing and is advantageous in detecting pathogens without a
priori knowledge.
Sequencing technology has revolutionized infectious diseasesresearch over the past decade. Whole-genome sequencing
(WGS) of pure cultures has been widely used for pathogen char-
acterization, evolutionary studies, transmission investigations,
and outbreak detection (1, 2, 3). WGS of cultured isolates is now
moving from the proof-of-concept phase to implementation. The
two major applications of WGS of cultured strains in clinical di-
agnostic microbiology are molecular epidemiology and antibiotic
resistance gene prediction (4). In contrast to theWGS sequencing
of cultured isolates, metagenomics assesses a community of or-
ganisms but eliminates the isolation step. This can be done by
focusing on a specific conserved gene, such as the 16S rRNA gene,
or by themetagenomic shotgun sequencing (MSS) of total micro-
bial nucleic acids within samples. For the purpose of this study,
metagenomics sequencing refers to either 16S rRNA gene se-
quencing or MSS; 16S rRNA gene sequencing and MSS using
next-generation sequencing (NGS) platforms produce large
quantities of data in a relatively short time. Although 16S rRNA
gene sequencing is less expensive thanMSS, it suffers from poten-
tial PCR-related bias. Taxonomical classification based on partial
16S rRNAgene sequencing is generally limited to phylum to genus
level specificity.Nevertheless, highly heterogeneous specieswithin
certain genera can be distinguished (5). In addition to the rela-
tively high cost, the large amount of sequence data generated by
MSS requires significant computing resources for data processing
and storage. However, MSS, without the bias inherent to PCR, is
capable of classifying bacteria to the species or strain level. It can
also detect viruses, fungi, and other microbial components, some
of which cannot yet be cultured (6).MSS has been used to identify
pathogens, including known and novel viruses that cause diarrhea
or fever (7, 8). Recently, MSS of cerebrospinal fluid from a coma-
tose patient with a congenital immunodeficiency revealed the un-
common pathogen Leptospira santarosai after extensive standard
testing had not yielded an etiologic agent (9).
Using metagenomic sequencing, the Human Microbiome
Project (HMP) demonstrated that millions of microbes coexist
with their healthy hosts (10). In such individuals, many of these
microbes maintain symbiotic relationships with their hosts, in-
cluding assisting in food digestion and immune modulation (11).
Some microbes may be residing latently or subclinically in a
healthy host but may cause disease at a later time. For example,
opportunistic organisms, such as Clostridium difficile, Staphylo-
coccus aureus,Acinetobacter baumannii, andCandida albicans, can
affect people with compromised immune systems but often colo-
nize without causing disease. Similarly, many viruses were de-
tected in the healthy subjects from the HMP cohort, including
herpesviruses and papillomaviruses (12). While not causing overt
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disease at the time of sampling, these viruses can become prob-
lematic if the subject becomes immunocompromised or if cofac-
tors predispose to cancer. Additionally, MSS has uncovered alter-
ations in microbial communities that are associated with a wide
range of disease (13, 14, 15). For example, compared to healthy
controls, intestinal dysbiosis is evident in patients with diarrhea
caused by C. difficile or other intestinal pathogens (16).
Another attribute of whole microbial profiling is that it can be
used to identify coinfecting agents within a clinical specimen.
Current clinical approaches for investigating the copresence of
pathogens use multiplex PCR. However, MSS is not limited to
targeted organisms and can potentially identify the cooccurrence
of a wide panel of organisms. To date, few clinical metagenomic
sequencing studies have investigated pathogen cooccurrence in
clinical specimens.
Here, we conducted a proof-of-concept study with the goal of
evaluating the concordance of metagenomic sequencing and di-
agnostic and research laboratory testing in pathogen identifica-
tion. Twenty-two C. difficile-positive and 5 C. difficile-negative
diarrhea stool samples (by laboratory testing) were sequenced us-
ing 16S rRNA gene sequencing and MSS. C. difficile and viruses
identified from different approaches were compared.
MATERIALS AND METHODS
Diarrhea stool sample collection. Stool samples were obtained from a
previous study (17, 18) that identified inflammatory markers and viral
copathogens duringC. difficile infection. Stool samples frompatients with
diarrhea were collected from inpatient, outpatient, and emergency de-
partment visits at St. Louis Children’sHospital (SLCH) between July 2011
and July 2012. Patients were 18 years old with a variety of underlying
diseases. Patients with stool residuals of 1 ml were excluded from the
study. This study was approved by the Institutional Review Board of the
Washington University School of Medicine.
Pathogen detection by the diagnostic laboratory and research labo-
ratory. In the clinical diagnostic laboratory, a glutamate dehydrogenase
enzyme immunoassay (EIA) (Wampole C. diff Quik Chek; Alere, Or-
lando, FL) was used to screen for C. difficile. Positive samples were con-
firmed by GeneXpert C. difficile PCR (Cepheid, Sunnyvale, CA). The two
assays were performed according to the manufacturers’ instructions. We
also performed quantitative PCR (qPCR) to evaluate the abundance of C.
difficile in the samples in our research laboratory, as described previously
(19). In brief, SYBR green-based real-time PCR was performed using the
7500 Fast real-time PCR system (Applied Biosystems) by including 10 l
of fast SYBR greenmastermix (Applied Biosystems), 0.5Mprimers, and
50 to 100 ng of nucleic acid in a 20 l PCR. Monoplex TaqMan reverse
transcription-PCR (RT-PCR) was also performed to detect the presence
of norovirus and sapovirus as described previously (17, 20). In brief,
primer/probe sets, reaction buffers, and a 100 ng template were mixed in
a final 25-l reaction volume. The RT-PCR was performed for 10 min at
45°C (reverse transcription temperature), 10 min at 95°C (Taq polymer-
ase activation), 45 cycles of 15 s at 95°C, and 1min at 60°C. Twenty-twoC.
difficile PCR-positive samples in addition to 5 samples from patients with
diarrhea whose C. difficile PCRs were negative in the clinical diagnostic
laboratory were selected for 16S rRNA gene sequencing and whole-
genome shotgun sequencing.
Metagenomic sequencing and analysis. Total nucleic acid (DNA and
RNA)was extracted using theNucliSens easyMag automated system (bio-
Mérieux,Marcy l’Etoile, France) according to themanufacturer’s instruc-
tions. In brief, samples were placed in the sample vessel andwere followed
by lysis incubation. Magnetic silica was added to the samples followed by
the automatic extraction. 16S rRNA gene sequencing and MSS were per-
formed in theMcDonnell Genome Institute at theWashingtonUniversity
School of Medicine. Preparation of 16S rRNA gene libraries, sequencing,
and data processing followed the standard operational protocols of the
Human Microbiome Project (HMP) consortium (21). Briefly, the V3 to
V5 region of the 16S rRNA gene was amplified using primers 357F
(5=-CCTACGGGAGGCAGCAG-3=) and 926R (5=-CCGTCAATTCMTT
TRAGT-3=). PCR was performed with the following conditions: 30 cycles
of 95°C for 2 min, 50°C for 0.5 min, and 72°C for 5 min. Amplicons were
purified, pooled at equimolar concentrations, and pyrosequenced on the
Roche 454 Titanium platform. Samples were binned by allowing onemis-
match in the barcode. Low-quality reads (average quality of 35 for a
read), short reads (200 bp), and reads with chimeric 16S rRNA gene
sequences were removed. High-quality sequences were classified from the
phylum to genus levels by the Ribosomal Database Project Naive Bayesian
Classifier version 2.5 using training set 9. As C. difficile is distinct from
otherClostridia based on the 16S rRNA gene (97% identity), we further
classified Clostridium reads to C. difficile by blasting them against a clos-
tridial database that we constructed by incorporating all Clostridium spe-
cies in the RDP (https://rdp.cme.msu.edu/classifier/classifier.jsp) and
Silva (http://www.arb-silva.de/) databases. The top hit with at least 97%
identity and 97% coverage to the referencewas designated theClostridium
species for a 16S rRNA gene sequence. If a read had the same bit score for
more than oneClostridium species, it was designated an unclassifiedClos-
tridium spp. To avoid read depth biasing the detection of C. difficile, all
samples were subsampled to 3,000 reads/sample.
For MSS, single-indexed sequencing libraries were constructed from
total nucleic acid with insert sizes of 300 to 500 bp. In brief, total nucleic
acid was subjected to reverse transcription and second strand synthesis to
convert the RNA to DNA using random primers (22). The DNAwas then
sheared using the Covaris instrument, and library construction was per-
formed using standard methods for end repair, A-tailing, adaptor liga-
tion, and amplification using the Phusion enzyme (NEB). Libraries were
pooled (7 to 8 samples per lane). MSS was performed on the Illumina
HiSeq platform, and 100 base-paired end readswere generated.MSS reads
were subjected to quality trimming, host contamination removal, and
low-complexity region masking. The subsequent sequences were aligned
to microbial databases using RTG mapping (Real Time Genomics)
against5,000 reference genomes (23) with the following parameters: –
repeat-freq 97% -e 10% -T 4 –w 15 –n 255. Alignments against bacterial
and fungal genomes were performed with the unique mapping mode of
RTG, inwhich only the reads uniquely aligned to a reference genomewere
used for bacterial and fungal species identification. The species relative
abundances were normalized by taking into account the number of reads
and the length of the reference genomes that the reads hit. For virus iden-
tification, alignments were performed as described previously (12).
Briefly, a nucleotide sequence alignment was performed with RTG (–re-
peat-freq 97% -e 10% -T 4 –w 15 –n 255 –top-random). Unaligned se-
quences were further interrogated for viruses. Translated alignments were
carried out using MBLASTX software (MulticoreWare) (24) against a
database of translated sequences from all of the viral reference genomes
with the following parameters: -m32 –e 1e-02 –I 50. Virus sequenceswere
confirmed to be unambiguously viral by realignment to larger nucleotide
(NT) and nonredundant (NR) databases using RTG mapping and
MBLASTX with the same parameters described above. Sequences were
counted as viral only if there were no similar alignments to other taxo-
nomic divisions. Because the single-index sequencing libraries were
pooled, some incorrect binning of sequences was expected (25). In order
to address this conservatively, we disregarded relatively low virus counts
from samples in the same pool with a sample that had a relatively high
number of reads for the same virus.
To determine the presence of resistance genes in the metagenomic
samples, human-free and high-quality WGS reads were mapped to the
Antibiotic Resistance Genes Database (ARDB) (http://ardb.cbcb.umd
.edu/). The resistance gene was defined as present when the reads had
100% identity to the reference gene, and the reference gene was covered
100% in length by the reads mapped to the gene.
Pathogen Identiﬁcation by Metagenomics
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Molecular validation of pathogens identified by sequencing. PCR
primers Cdiff16s-F (5=-AGCTCTTGAAACTGGGAGACTTGAG-3=)
and Cdiff16s-R (5=-AGGGAACTCTCCGATTAAGGAGATGTC-3=),
designed to amplify the 16S rRNA gene of C. difficile (26), were used to
confirm the presence ofC. difficile in samples that wereC. difficile negative
by qPCR (detected the tcdB gene) but positive by sequencing. Real-time
PCR was performed (27) to detect Salmonella enterica in samples that
were S. enterica negative in the diagnostic laboratory (by culture) but
positive by sequencing. Parechovirus and anellovirus, which were dis-
covered byMSS, were further validated by PCR as described previously
(28, 29).
Nucleotide sequence accession number. All reads were deposited in
the Sequence Read Archive database at NCBI under accession number
PRJNA293986.
RESULTS AND DISCUSSION
Comparison of C. difficile detection by metagenomic sequenc-
ing and qPCR. To determine the concordance between sequenc-
ing andmolecular-based techniques in the detection ofC. difficile,
22 C. difficile-positive stool samples from patients with diarrhea
detected by PCR in the diagnostic laboratory and qPCR in our
research laboratory were selected for sequencing with 16S rRNA
gene sequencing and MSS. We also sequenced five C. difficile-
negative stool samples (by EIA and PCR) from the patients who
had diarrhea. These samples served as symptomatic controls for
diarrhea caused by C. difficile. The potential causes, based on cul-
tures and medical records, for the diarrhea in symptomatic con-
trols were Campylobacter and Salmonella infections, drug side ef-
fect, inflammatory bowel disease (IBD), and unknown, respec
tively.
The relative abundances of C. difficile ranged from 0.02% to
45.4% as measured by 16S rRNA gene sequencing in C. difficile-
positive samples. CFU (range, 106 to 10,957,641/ml) calculated
from qPCR (17) were positively correlated with the relative abun-
dances of C. difficile from 16S rRNA gene sequencing (Pearson
correlation, r20.60; P 0.001) (Fig. 1A), which corroborated
that the two approaches to C. difficile quantification produced
similar results. Specifically, C. difficile was detected by 16S rRNA
gene sequencing in 20 (90.9%) of the 22 samples that were qPCR
positive (threshold cycle [CT] value of46) (Table 1). Two sam-
ples in which C. difficile was not detected by 16S rRNA gene se-
quencing (CT values of 29.7 and 31.5) produced an abundance of
16S rRNAgene reads (4,813 and 11,468, respectively), so sampling
depth was not an issue.
Surprisingly, we also detected a sparse C. difficile presence by
16S rRNA gene sequencing in two symptomatic control samples.
The clinical diagnoses for these two samples were drug side effect
and Salmonella infection. TheC. difficile readswere blasted against
the NT database to further validate the specificity of the taxon
calling. C. difficile was the top hit with a high identity (97%),
which suggests that those reads are likely from C. difficile. Because
the qPCR was negative for the tcdB gene and 16S rRNA genes are
indistinguishable between toxigenic and nontoxigenic C. difficile,
we first reasoned that these reads may be from nontoxigenic C.
difficile. Primers designed to specifically amplify theC. difficile 16S
rRNA genewere used to validate the presence ofC. difficile regard-
less of the toxin genes. PCR assay for the 16S rRNA gene was
negative for the two symptomatic control samples. The detection
of C. difficile by 16S sequencing but the lack of confirmation by
PCR from the original samples suggests that the C. difficile reads
may be from contamination in different steps of the study. Be-
cause the PCR of the C. difficile-specific 16S rRNA gene is a gel-
based assay, the rareness ofC. difficile in the samples (only 5 and 7
reads were detected in the 16S rRNA gene sequencing) can also
lead to the negative observation from the gel. Themain goal of the
study is to assess the general concordance of pathogen identifica-
tion by sequencing and laboratory testing. The discordance in the
above samples prompts us to further investigate the factors (se-
quencing depth and source of contamination) in greater detail in
future study. In addition, because 16S rRNAgene sequencing does
not differentiate toxigenic and nontoxigenicC. difficile, 16S rRNA
gene sequencing used for the detection of C. difficile may have a
similar utility as the EIA in the diagnostic laboratory.
We detected Campylobacter and Salmonella by 16S rRNA gene
sequencing in two symptomaticC. difficile-negative butCampylo-
bacter- and Salmonella-positive samples.
As shown in Fig. 1B, the abundances of C. difficile from MSS
agreed with the qPCR results (Pearson correlation, 0.55) and
showed the same trend as 16S rRNA gene sequencing (Pearson
correlation, 0.98). MSS successfully detectedC. difficile in all sam-
ples with CT values of20, 86.7% of samples with CT values of 20
to 35, and 75% of samples with CT values of 35 to 46. Three sam-
ples that were qPCR positive were negative by MSS (Table 1), but
these samples had the lowest MSS read depth, which suggested
that the inability to detect C. difficile by MSS in these cases may
have been due to insufficient read depth. We also detected a low
FIG 1 Correlation of qPCRwithmetagenomic sequencing in detection ofC. difficile in the diarrhea samples. CFU derived from qPCRwere positively correlated
with the relative abundances of C. difficile detected by 16S rRNA gene sequencing (A) and MSS (B).
Zhou et al.
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abundance of C. difficile by MSS in the sample from the Campy-
lobacter control in which C. difficile was not detected by PCR.
Alignment of the sequences to the NT database confirmed the
specificity of the reads to C. difficile. However, a gel-based PCR
with amplification for the 16S rRNA gene from the original sam-
ples failed to support the presence ofC. difficile. Thismay be due to
the same artifact noted above. MSS successfully detected Campy-
lobacter and Salmonella in two controls that were known to con-
tain these agents by PCR andwere also detected by 16S rRNA gene
analysis.
We also performed reverse transcription-quantitative PCR
(qRT-PCR) to determine if norovirus and sapovirus were present
in these samples and compared the detection sensitivity withMSS.
Five samples were norovirus positive and 3 samples were sapovi-
rus positive by qRT-PCR (Table 1), four samples were norovirus
positive and 2 samples were sapovirus positive byMSS, and noro-
virus and sapovirus were detected in 3 and 2 sample by qRT-PCR
and MSS, respectively. The correlation between MSS and qRT-
PCR in viral detection was low. This is probably because viral
genomes are small and, therefore, viral nucleic acid often accounts
for a relatively small proportion of the total nucleic acid from a
sample if the virus is not abundant and because the MSS proce-
dure in this study did not include the viral enrichment step that is
sometimes used for viral discovery. Our previous work showed
that sequencing depth affects the sensitivity of viral detection in
clinical samples. Increased sequence depth (i.e., 20 million reads/
sample) strengthens vial signals and allows for novel viral detec-
tion (8).
In summary, the targeted 16S rRNA gene sequencing and the
MSS showed moderate correlation in C. difficile identification
compared to that of diagnostic laboratory and research laboratory
testing. The consistency of the MSS and qRT-PCR was lower for
the detection of low-abundance organisms, such as viruses. One
limitation of this study is its small sample size, especially because it
included relatively few virus-positive samples. Future studies with
larger sample sizeswill providemore insights into the sensitivity of
PCR and MSS in the detection of viral pathogens. Discordance
between sequence-positive and PCR-negative samples deserves
further investigation.
Whole microbiome community revealed by MSS. Figure 2
illustrates the microbial community compositions and abun-
dances from the 27 diarrhea samples using MSS. C. difficile and
any organisms present in greater abundance than C. difficile were
included in the heatmap. First, the relative abundance of C. diffi-
cile in the bacterial communities fromMSS varied widely, ranging
from 0.005% to 6.7% of total reads in theC. difficile-positive sam-
ples. It is not clear what level of C. difficile can cause diarrhea, but
our recent study showed that the load of C. difficile was not asso-
ciated with clinical outcome (19). Second, the microbial commu-
nities were quite distinct in the C. difficile-positive samples
TABLE 1 Detection of the copresence of bacteria and viruses in the diarrhea samples
Sample identification
C. difficile detection by:
C. perfringens detection
by 16SMSS
Norovirus
detection by:
Sapovirus detection
by:
qPCR 16S MSS qRT-PCR MSS qRT-PCR MSS
CDAF.131.131 a   b    
CDAF.136.136        
CDAF.137.137        
CDAF.139.139        
CDAF.142.142        
CDAF.143.143        
CDAF.178.178        
CDAF.180.180        
CDAF.193.193        
CDAF.198.198        
CDAF.218.218        
CDAF.224.224        
CDAF.230.230        
CDAF.231.231        
CDAF.243.243        
CDAF.245.245        
CDAF.267.267        
CDAF.41949.A        
CDAF.41951.C        
CDAF.41953.E        
CDAF.41955.G        
CDAF.41958.J - C. difficile Salmonella        
CDAF.41950.B -NCc (medicine side effect)  d      
CDAF.41952.D-NC (inflammatory bowel disease)        
CDAF.41954.F-NC (Campylobacter)   d     
CDAF.41956.H-NC (unknow cause)        
CDAF.41957.I-NC (Salmonella)  d      
a, Present in the sample.
b, Not present in the sample.
c NC, negative control.
d Detected by sequencing but not confirmed by 16S rRNA gene PCR.
Pathogen Identiﬁcation by Metagenomics
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(Fig. 2). The dominant species in themajority of the samples were
commensal gut flora, including Bacteroides spp. and Ruminococ-
cus spp., which are the major enterotypes identified in healthy
human stool (30). We also found that one patient sample was
dominated by Candida spp. (35.5% of relative abundance). Inter-
estingly, this patient was a symptomatic C. difficile-negative con-
trol patient without another clear cause of diarrhea. We further
found this patient was treated with several antibiotics, including
gentamicin, nafcillin, rifampin, trimethoprim-sulfamethoxazole,
and vancomycin in the 3 months before diarrhea occurred. It is
unclear whether fecal domination with Candida is a cause of diar-
rhea or simply a consequence of antibiotic therapy (31), but either
observation has clinical relevance and would not have been iden-
tified by the cultures or PCR-based diagnostic studies typically
performed in the clinical laboratory on stool samples.
Diverse microbial communities from patients with the same
clinical symptoms are not surprising, as the microbiota are highly
variable even between healthy subjects (32). Age, geographical
location, diet, and environmental factors all potentially affect mi-
crobial community structure. The high intersubject variation of
the bacterial communities in a diarrheal conditionmay reflect the
inherent variation of gut microbiota before the patients had diar-
rhea. Antibiotic usage, long-termdiet, and the underlying diseases
in those patients may also contribute to the microbial variation
between patients in the disease status.
Detection of pathogen copresence in diarrhea samples by
MSS. A major advantage of metagenomic sequencing for patho-
gen identification is its potential to detect simultaneous coinfec-
tion with multiple pathogens, including bacteria and viruses. Few
studies have reported the frequency of pathogenic bacterial coin-
fection with C. difficile infection. In this study, we focused on
Clostridiumperfringens to determine its copresencewithC. difficile
because it is a common clinically diagnosed bacterial pathogen
that causes diarrhea. In addition, 16S rRNA gene sequencing is
capable of identifying C. perfringens at the species level (33). Con-
sidering the difficulty of detecting low-abundance organisms us-
ing the metagenomic approach, the presence of C. perfringenswas
designated only when the organismwas identified by both the 16S
FIG 2 Microbial community profile of the diarrhea samples revealed by MSS. The distribution of C. difficile and the taxa whose relative abundances are higher
than that ofC. difficile are illustrated by heatmap. Each row represents a taxon, and each column represents a sample. The samples are in the same order as Table
1. Relative abundances with log10 transformation are used in the heatmap.
Zhou et al.
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rRNA gene approach and MSS. C. perfringens was found to be
copresent withC. difficile in oneC. difficile-positive sample (Table
1). We also found C. perfringens in a symptomatic control patient
whose diarrhea was thought to be caused by medications. The
detection of C. perfringens raises another etiologic possibility. C.
perfringenswas also detected in IBD- and S. enterica-symptomatic
control samples. The presence of C. perfringens was further vali-
dated by aligning the reads to the NT database.
Viral pathogens were also detected in C. difficile-positive sam-
ples by MSS. In addition to norovirus and sapovirus detected by
qRT-PCR assays, we also detected anellovirus and parechovirus
using MSS. These two viruses were not tested by our diagnostic
and research laboratories before sequencing. We later confirmed
the presence of the two viruses by PCR assay, as described in the
Materials and Methods. The four viral genera were detected in
27.3% (6/22) of C. difficile-positive samples and 1 symptomatic
control. Norovirus was the most prevalent virus in these samples,
as it was detected in 18.2% (4/22) of the C. difficile-positive sam-
ples. We also found a copresence of norovirus, C. difficile, and C.
perfringens in 1 sample. Sapovirus was found in 1 C. difficile-pos-
itive sample and 1 symptomatic control sample with an unknown
cause of diarrhea from the clinical lab. As described above, we
found that Candida was predominant in this symptomatic con-
trol. Of the above viruses, only norovirus and sapovirus are asso-
ciated with diarrhea (21). It is unclear whether they may be the
primary or secondary cause of the symptoms observed in these
patients. These viruses are also sometimes detected in asymptom-
atic individuals. Viral detection bymultiplex PCR iswidely used in
clinical diagnostic laboratories. Because viral detection usingMSS
can detect unexpected and novel viruses, it should be considered
an alternative tool for viral discovery, especially when antigen de-
tection and PCR fail to detect such agents.
Of note, the accuracy of microbial identification from MSS
depends on the completeness of the reference database and the
relatedness of clinical query strains to the reference strains in
the database. Furthermore, the sequencing depth is likely to affect
the robustness of the metagenomic approach. Because of the dif-
ficulties in recovering the whole genome of a bacterium or virus
from a complex metagenomic sample, the species identification is
based on read depth and the coverage of the reference genome.
Therefore, MSS data should be interpreted with caution, espe-
cially given the low abundances of the pathogens we found in
some of the specimens. Finally, the interpretation of simultaneous
detection of C. difficile along with other pathogenic bacteria and
viruses in the same patient requires further study. The current
analytical approach only supports their concomitant presence in
the gut environment but does not indicate which of the agents is
responsible for disease manifestations. Using approaches includ-
ing multiplex PCR and sequencing to facilitate the diagnosis of
infectious diseases provides greater understanding of the diseases
while also raising the question of which is the real causative agent.
Antibiotic resistance prediction from metagenomic se-
quences. Using strict criteria to define the presence of antibiotic
resistance genes, we identified 27 antibiotic resistance genes in our
FIG 3 Prevalence of antibiotic resistance genes. The prevalence of antibiotic resistance genes is illustrated by a bar plot. The antibiotic categories are listed on the
left side of the bar plot.
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samples, and 55.6% of the samples contained at least one such
locus. The most prevalent antibiotic resistance genes were
Bl2e_cfxa (25.9%) and tetQ (25.9%) (Fig. 3), encoding a class A
beta-lactamase that confers resistance to cephalosporin and tetra-
cycline resistance, respectively. ermA, ermB, ermF, and ermG
genes, which are responsible for resistance to macrolide antibiot-
ics, were also identified in 3.7% to 11.1% of the samples. tet genes
are the most common resistance genes identified in stool samples
from healthy adults (34, 35). Indeed, a recent study indicated that
tetracycline, beta-lactamases, and multiple drug resistance genes
were commonly found in the stool of children12months of age
(36). We also identified genes encoding multidrug efflux system
proteins in one sample. Whole-genome shotgun sequencing of
cultured bacteria revealed antibiotic resistance phenotypes with
high accuracy. MSS has the capability to identify the resistance
genes in the whole bacterial community. To pin down the bacte-
rial origin of the resistance, deep sequencing and subsequent as-
sembly of the bacterial genomeor other alternative approaches are
needed.
Conclusion. In summary, MSS correlates well with standard
clinical diagnostic laboratory testing and qPCR in a research lab-
oratory in its ability to identify C. difficile. It enables detection of
multiple potential pathogens without a priori knowledge in clini-
cal samples. Future amplicon-based sequencing targeting full-
length 16S rRNA genes and rRNA internal transcribed spacers
(ITS) (37) is likely to increase the resolving power of the taxo-
nomic classification of bacteria. This ever-evolving sequencing
technology aims to lower sequence cost, increase throughput, and
decrease turnaround time. These developments will expedite the
implementation of sequencing technology in diagnostic testing in
the clinic.
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